BAK/Cervical Interbody Fusion System
PMA P980048
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPRL | NumberP980048 | Date20 Apr 2001 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Full name
- Bak/Cervical (Bak/C) (R) Interbody Fusion System
- Trade Name
- Bak/Cervical (Bak/C) Interbody Fusion System
- Generic Name
- Intervertebral fusion device with bone graft, lumbar
- PMA Number
- FDA Product Code
- MAX
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3080
- Advisory Committee
- Orthopedic
- FDA Decision
- APRL
Overview
AI-generated summary, 18 Sep 2026
The BAK/Cervical Interbody Fusion System is an intervertebral fusion device designed for skeletal mature patients with degenerative disc disease (DDD) in the cervical spine, accompanied by radicular symptoms at a single disc level. It is intended to facilitate spinal fusion by providing structural support and stability at the C-3 to C-7 disc levels, using an anterior surgical approach in conjunction with autograft bone.
This system is supplied sterile and intended for single-use, with FDA_PMA authorization under PMA number P980048. Implants are placed via an anterior approach, and the device is regulated under the orthopedic product code MAX. Storage and handling must comply with sterile surgical instrument protocols, as specified in the accompanying instructions for use.
Other devices from Sulzer Spine-Tech
Questions
AI-generated answers, 18 Sep 2026
What cervical spine levels is the BAK/Cervical Interbody Fusion System approved for use in patients with degenerative disc disease and radicular symptoms?
The BAK/Cervical Interbody Fusion System is approved for use at the C-3 to C-7 disc levels in skeletally mature patients with degenerative disc disease (DDD) and accompanying radicular symptoms at a single disc level. This is based on the device’s intended use as described in the advisory committee statement and PMA authorization.
How is the BAK/Cervical Interbody Fusion System supplied, and is it reusable?
The BAK/Cervical Interbody Fusion System is supplied sterile and is intended for single-use only. Since it is designed for surgical implantation and sterilized for one-time use, reuse is not recommended or supported by the manufacturer or regulatory approval.
What surgical approach is required to implant the BAK/Cervical Interbody Fusion System, and what additional materials are needed?
The BAK/Cervical Interbody Fusion System is placed via an anterior surgical approach at the specified cervical disc levels. The device is intended to be used in conjunction with autograft bone to facilitate spinal fusion, as outlined in the device description and advisory committee statement.
How should the BAK/Cervical Interbody Fusion System be stored, and what precautions should be taken?
The BAK/Cervical Interbody Fusion System must be stored and handled according to sterile surgical instrument protocols to maintain its sterility. Since it is supplied sterile, proper packaging integrity and adherence to manufacturer instructions are critical to prevent contamination before use.